Kershen Richard T, Dmochowski Roger R, Appell Rodney A
Scott Department of Urology, Baylor College of Medicine, 6562 Fannin, Suite 2100, Houston, TX 77030, USA.
Urol Clin North Am. 2002 Aug;29(3):559-74. doi: 10.1016/s0094-0143(02)00066-6.
Previous experience with GAX-collagen has shown that the endoscopic correction of female SUI is both possible and effective. It is clear, however, that durability remains a primary concern when implementing this approach to treatment. The availability of recently developed and newly emerging materials, carefully designed using the tenets and techniques of biotechnology and materials science, may provide solutions to some of the difficulties beleaguering this treatment option. Results with currently available injectables are summarized in Table 1. Careful review and critical analysis of new bulking agents will soon reveal which materials approach the therapeutic ideal. It is likely that the ultimate choice of a particular substance, synthetic or biologic, may best be determined by the clinical circumstances involving the individual patient.
先前使用GAX胶原蛋白的经验表明,内镜下矫正女性压力性尿失禁是可行且有效的。然而,很明显,在采用这种治疗方法时,耐久性仍然是一个主要问题。利用生物技术和材料科学的原理与技术精心设计的最新研发和新出现的材料,可能会为困扰这种治疗选择的一些难题提供解决方案。目前可用注射剂的结果总结在表1中。对新型填充剂进行仔细审查和批判性分析,很快就会揭示哪些材料接近治疗理想状态。特定物质(合成的或生物的)的最终选择很可能最好由涉及个体患者的临床情况来决定。